Suppr超能文献

在晚期乳腺癌细胞系中存在大量独特的端粒t-残端簇。

Abundance of a distinct cluster of telomere t-stumps in advanced breast cancer cell line.

作者信息

Pai Rekha B, Pai S Balakrishna, Yang Lily, Joshi Harish C

机构信息

Department of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322.

出版信息

Oncol Lett. 2010 Mar;1(2):339-343. doi: 10.3892/ol_00000060. Epub 2010 Mar 1.

Abstract

Breast tumors are the second major cause of cancer-related death in women worldwide. These tumors are aggressive, leading to metastatic cancers that are heterogeneous in nature, with numerous subtypes. The basal-like tumor subtype invariably shows unfavorable prognosis and is often characterized by the lack of estrogen, progesterone and HER2 receptors. These cancer types do not respond to the current targeted therapies. Therefore, the need for the discovery of novel diagnostic markers/therapeutic targets is of paramount importance. Immortalization of breast tumor cells leading to advanced stage cancer is one of the pivotal steps in breast cancer and telomeres/telomerase play a critical role in this process. Using single telomere length analysis, cell lines with a basal-like phenotype encompassing immortalized/non-tumorigenic MCF10A and invasive/metastatic MCF10CA1 along with the MCF-7 cell line were examined for the presence of a unique class of telomere t-stumps. Telomerase activity, protein levels of telomerase and bulk telomere lengths were assessed in the above-mentioned cell lines. This is the first study describing the existence of a distinct class of extremely short telomeres termed 't-stumps' in breast cancer cell lines. The cell lines MCF10A and MCF10CA1 showed distinct telomeric bands in the molecular size range of 100-1,000 bp, whereas the MCF-7 cell line showed very low levels of t-stumps. Of note is that only the highly invasive/metastatic cancer cell line MCF10CA1 exhibited an abundance of a cluster of t-stumps with a size distribution range of 500-700 bp. These unique t-stumps observed in the advanced breast cancer cell line may serve as a novel diagnostic marker and also form a key molecular target for novel anticancer therapy.

摘要

乳腺癌是全球女性癌症相关死亡的第二大主要原因。这些肿瘤具有侵袭性,会导致本质上异质性的转移性癌症,有众多亚型。基底样肿瘤亚型总是显示出不良预后,其特征通常是缺乏雌激素、孕激素和HER2受体。这些癌症类型对当前的靶向治疗无反应。因此,发现新型诊断标志物/治疗靶点至关重要。乳腺肿瘤细胞永生化导致癌症进展是乳腺癌的关键步骤之一,端粒/端粒酶在此过程中起关键作用。使用单端粒长度分析,对具有基底样表型的细胞系进行检测,这些细胞系包括永生化/非致瘤性的MCF10A和侵袭性/转移性的MCF10CA1以及MCF-7细胞系,以检查是否存在一类独特的端粒t-残端。在上述细胞系中评估了端粒酶活性、端粒酶蛋白水平和总体端粒长度。这是第一项描述在乳腺癌细胞系中存在一类独特的极短端粒(称为“t-残端”)的研究。MCF10A和MCF10CA1细胞系在100 - 1000 bp的分子大小范围内显示出独特的端粒条带,而MCF-7细胞系显示出极低水平的t-残端。值得注意的是,只有高侵袭性/转移性癌细胞系MCF10CA1表现出大量大小分布在500 - 700 bp的t-残端簇。在晚期乳腺癌细胞系中观察到的这些独特的t-残端可能作为一种新型诊断标志物,也构成新型抗癌治疗的关键分子靶点。

相似文献

1
Abundance of a distinct cluster of telomere t-stumps in advanced breast cancer cell line.
Oncol Lett. 2010 Mar;1(2):339-343. doi: 10.3892/ol_00000060. Epub 2010 Mar 1.
2
Human cancer cells harbor T-stumps, a distinct class of extremely short telomeres.
Mol Cell. 2007 Oct 26;28(2):315-27. doi: 10.1016/j.molcel.2007.10.005.
4
Shorter telomeres and high telomerase activity correlate with a highly aggressive phenotype in breast cancer cell lines.
Tumour Biol. 2016 Sep;37(9):11917-11926. doi: 10.1007/s13277-016-5045-7. Epub 2016 Apr 12.
5
Treating Cancer by Targeting Telomeres and Telomerase.
Antioxidants (Basel). 2017 Feb 19;6(1):15. doi: 10.3390/antiox6010015.
6
Development of retinoblastoma in the absence of telomerase activity.
J Natl Cancer Inst. 1996 Aug 21;88(16):1152-7. doi: 10.1093/jnci/88.16.1152.

引用本文的文献

1
Single-Run Catalysis and Kinetic Control of Human Telomerase Holoenzyme.
Adv Exp Med Biol. 2022;1371:109-129. doi: 10.1007/5584_2021_676.
2
Telomere Homeostasis: Interplay with Magnesium.
Int J Mol Sci. 2018 Jan 5;19(1):157. doi: 10.3390/ijms19010157.
3
Three-dimensional Nuclear Telomere Organization in Multiple Myeloma.
Transl Oncol. 2013 Dec 1;6(6):749-56. doi: 10.1593/tlo.13613.

本文引用的文献

1
Short telomeres are preferentially elongated by telomerase in human cells.
FEBS Lett. 2009 Sep 17;583(18):3076-80. doi: 10.1016/j.febslet.2009.08.029. Epub 2009 Aug 29.
2
Short telomeres initiate telomere recombination in primary and tumor cells.
PLoS Genet. 2009 Jan;5(1):e1000357. doi: 10.1371/journal.pgen.1000357. Epub 2009 Jan 30.
3
Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia.
Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1187-92. doi: 10.1073/pnas.0807057106. Epub 2009 Jan 15.
4
Novel therapies in breast cancer: what is new from ASCO 2008.
J Hematol Oncol. 2008 Oct 1;1:16. doi: 10.1186/1756-8722-1-16.
6
Regulation of in situ to invasive breast carcinoma transition.
Cancer Cell. 2008 May;13(5):394-406. doi: 10.1016/j.ccr.2008.03.007.
7
Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.
Cancer Res. 2008 Feb 15;68(4):989-97. doi: 10.1158/0008-5472.CAN-07-2017.
8
Human cancer cells harbor T-stumps, a distinct class of extremely short telomeres.
Mol Cell. 2007 Oct 26;28(2):315-27. doi: 10.1016/j.molcel.2007.10.005.
9
Early replication of short telomeres in budding yeast.
Cell. 2007 Mar 23;128(6):1051-62. doi: 10.1016/j.cell.2007.01.041.
10
BRCA1 in hormonal carcinogenesis: basic and clinical research.
Endocr Relat Cancer. 2005 Sep;12(3):533-48. doi: 10.1677/erc.1.00972.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验